PIEZO1 and acute myeloid leukemia: Considering expression of PIEZO1 by quartiles, AML patients with the highest expression of PIEZO1 (above the third quartile, that is, the 25% of patients with the highest expression) had a significantly better overall survival (p = 0.028, Figure 1G) and leukemia‐free survival (p = 0.01, Figure 1H).